iFANN
    Buscar en iFANN...
    Iniciar sesión
    Inicio
    Noticias
    Vídeos
    Libros
    Fotos
    GIFs
    Explorar
    Encuestas
    Premios
    iFAMOUS
    Wiki
    Anime
    Salas
    Notificaciones
    Mensajes
    Guardados
    Perfil
    WikiPremiosiFAMOUSClasificacionesSectoresRecompensas para creadoresRecompensas para usuariosTérminosPrivacidadNormas de la comunidadRetirada / DMCAAyudaDesarrolladores

    © 2026 iFANN

    Inicio
    Buscar
    Mensajes
    Alertas
    Perfil

    Publicación

    Gloriaunhinged
    Gloriaunhinged@gloriaunhinged
    💭Health💭Science

    CARv3-TEAM-E glioblastoma trial MRI results

    What showed up on the scans five days after one infusion is the part doctors are still calling jaw-dropping. Three people with recurrent glioblastoma came to Massachusetts General Hospital in early 2024, and the therapy they got, CARv3-TEAM-E, is a CAR T-cell approach that starts with each patient's own immune cells. Those cells get genetically rewired in the lab so they recognize two markers that tend to sit on glioblastoma cells. Then they go straight into the fluid spaces of the brain, and it all happens through one procedure. From there the outcomes split in ways nobody was ready for. One patient's MRI at day five showed the tumor had nearly vanished. Another patient's tumor shrank by more than 60 percent, and that reduction held for over six months. The third patient had clear tumor reduction within days. Compare that with what immunotherapy had done for this type of brain cancer before, and the speed and the size of the response are on another level entirely. The early images being described as jaw-dropping feels less like hype and more like an understatement.

    1mo

    521 Me gusta31 No me gusta84 Reposteos24 Comentarios
    ?

    Comentarios

    Aún no hay comentarios. ¡Sé el primero!

    Publicación

    Gloriaunhinged
    Gloriaunhinged@gloriaunhinged
    💭Health💭Science

    CARv3-TEAM-E glioblastoma trial MRI results

    What showed up on the scans five days after one infusion is the part doctors are still calling jaw-dropping. Three people with recurrent glioblastoma came to Massachusetts General Hospital in early 2024, and the therapy they got, CARv3-TEAM-E, is a CAR T-cell approach that starts with each patient's own immune cells. Those cells get genetically rewired in the lab so they recognize two markers that tend to sit on glioblastoma cells. Then they go straight into the fluid spaces of the brain, and it all happens through one procedure. From there the outcomes split in ways nobody was ready for. One patient's MRI at day five showed the tumor had nearly vanished. Another patient's tumor shrank by more than 60 percent, and that reduction held for over six months. The third patient had clear tumor reduction within days. Compare that with what immunotherapy had done for this type of brain cancer before, and the speed and the size of the response are on another level entirely. The early images being described as jaw-dropping feels less like hype and more like an understatement.

    1mo

    521 Me gusta31 No me gusta84 Reposteos24 Comentarios
    ?

    Comentarios

    Aún no hay comentarios. ¡Sé el primero!